About this trial
This research is studying the use of low-intensity focused ultrasound (LIFU; a mild, noninvasive acoustic stimulation technique) in a small number of people to learn about its safety as a treatment for stuttering. LIFU is a small, safe sound signal that produces a gentle, pulsing flow of acoustic waves to help different parts of the brain communicate with each other. Researchers want to understand how the mild, non-invasive brain stimulation affects speech relevant brain areas, which may in turn affect speech fluency and speaking-related brain activity in people who stutter.
Eligibility criteria
Qualifiers
have normal language, hearing and cognition
speak English as their primary language
currently stutter
score at least 10 (very mild) on the Stuttering Severity Instrument (SSI-4) or exhibit greater than 3% stuttered syllables during at least one of the first 3 speech samples
Disqualifiers
History of seizures
Major medical or neurological illness (e.g., stroke, serious head trauma, brain infection, Parkinson's disease, etc.)
History of closed head injury with loss of consciousness (e.g., concussion)
Metal or electronic implants such as cochlear implants and pacemakers
Trial design
Treatments tested in this trial
- High DC LIFU
- Sham
Treatment groups
Sponsors and collaborators
University of Michigan
Lead sponsor
Michigan Pioneer Fellowship
Collaborator